Machine Learning Models predicting Decompensation in Cirrhosis

被引:0
作者
Mueller, Sophie Elisabeth [1 ,2 ]
Casper, Markus [1 ]
Ripoll, Cristina [3 ,4 ]
Zipprich, Alexander [3 ,4 ]
Horn, Paul [3 ,5 ]
Krawczyk, Marcin [1 ]
Lammert, Frank [1 ,6 ]
Reichert, Matthias Christian [1 ]
机构
[1] Saarland Univ, Med Ctr, Dept Med 2, Kirrberger Str 100, D-66421 Homburg, Germany
[2] Saarland Univ, Inst Med Microbiol & Hyg, Ctr Infect Dis, Homburg, Germany
[3] Univ Hosp Jena, Dept Internal Med 4, Jena, Germany
[4] Univ Hosp Halle, Clin Internal Med 1, Halle, Germany
[5] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany
[6] Hannover Med Sch MHH, Hlth Sci, Hannover, Germany
关键词
artificial intelligence; cirrhosis; decompensation; liver; machine learning; SPONTANEOUS BACTERIAL PERITONITIS; ALBUMIN-BILIRUBIN GRADE; IN-HOSPITAL MORTALITY; STAGE LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; NONINVASIVE TESTS; NEURAL-NETWORK; CHILD-PUGH; NOD2; GENE; PROGNOSIS;
D O I
10.15403/jgld-5876
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Decompensation of cirrhosis significantly decreases survival, thus, prevention of complications is paramount. We used machine learning techniques to identify parameters predicting decompensation. Methods: Several machine learning techniques were applied to the INCA trial database containing pro-and retrospective data from 983 patients. Laboratory, clinical, and genetic data were analysed. After performing hierarchical clustering, Permutation Feature Importance was used to evaluate the impact of parameters on the prediction of decompensation. Results: Achieving an accuracy of 81.6% on training and 70.5% on test data, Random Forests were best for retrospective prediction. In prospective assessment, Support Vector Machines performed best with an accuracy of 78.6% and 73.8%, respectively. Permutation Feature Importance demonstrated that baseline albumin and bilirubin levels and maximum bilirubin were the highest ranked parameters associated with former decompensation. In the prospective analysis, the maximum bilirubin value and the baseline values of sodium and albumin were ranked highest. In addition to the parameters of established scores, NOD2 genotype and inflammatory markers were highly ranked. Conclusions: Laboratory parameters, genetic variants and infections can help to predict the risk of cirrhosis decompensation. This proof-of-concept study adds data for the future development of advanced models to identify patients at risk.
引用
收藏
页码:71 / 80
页数:10
相关论文
共 49 条
  • [1] D'Amico G, Garcia-Tsao G, Pagliaro L., Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies, J Hepatol, 44, pp. 217-231, (2006)
  • [2] Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R., Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, 60, pp. 646-649, (1973)
  • [3] Kamath PS, Wiesner RH, Malinchoc M, Et al., A model to predict survival in patients with end-stage liver disease, Hepatology, 33, pp. 464-470, (2001)
  • [4] Kamath PS, Kim WR, The model for end-stage liver disease (MELD), Hepatology, 45, pp. 797-805, (2007)
  • [5] Cholongitas E, Senzolo M, Triantos C, Samonakis D, Patch D, Burroughs AK., MELD is not enough--enough of MELD?, J Hepatol, 42, pp. 475-479, (2005)
  • [6] Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK., Systematic review: The model for end-stage liver disease--should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis?, Aliment Pharmacol Ther, 22, pp. 1079-1089, (2005)
  • [7] Bernardi M, Gitto S, Biselli M., The MELD score in patients awaiting liver transplant: strengths and weaknesses, J Hepatol, 54, pp. 1297-1306, (2011)
  • [8] Johnson PJ, Berhane S, Kagebayashi C, Et al., Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade, J Clin Oncol, 33, pp. 550-558, (2015)
  • [9] Toyoda H, Lai PBS, O'Beirne J, Et al., Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade, Br J Cancer, 114, pp. 744-750, (2016)
  • [10] Hiraoka A, Kumada T, Michitaka K, Et al., Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma, J Gastroenterol Hepatol, 31, pp. 1031-1036, (2016)